Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 277 to 288 of 288 entries
Sorted by: Best Match Show Resources per page
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.

Cancer medicine

Jones RL, Herzog TJ, Patel SR, von Mehren M, Schuetze SM, Van Tine BA, Coleman RL, Knoblauch R, Triantos S, Hu P, Shalaby W, McGowan T, Monk BJ, Demetri GD.
PMID: 33960681
Cancer Med. 2021 Jun;10(11):3565-3574. doi: 10.1002/cam4.3903. Epub 2021 May 07.

BACKGROUND: As with other alkylating agents, cardiac dysfunction can occur with trabectedin therapy for advanced soft tissue sarcomas (STS) or recurrent ovarian cancer (ROC) where treatment options for advanced disease are still limited. Cardiac safety for trabectedin monotherapy (T)...

Cite
Jones RL, Herzog TJ, Patel SR, et al. Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med. 2021;10(11):3565-3574doi: 10.1002/cam4.3903.
Jones, R. L., Herzog, T. J., Patel, S. R., von Mehren, M., Schuetze, S. M., Van Tine, B. A., Coleman, R. L., Knoblauch, R., Triantos, S., Hu, P., Shalaby, W., McGowan, T., Monk, B. J., & Demetri, G. D. (2021). Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer medicine, 10(11), 3565-3574. https://doi.org/10.1002/cam4.3903
Jones, Robin L, et al. "Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer." Cancer medicine vol. 10,11 (2021): 3565-3574. doi: https://doi.org/10.1002/cam4.3903
Jones RL, Herzog TJ, Patel SR, von Mehren M, Schuetze SM, Van Tine BA, Coleman RL, Knoblauch R, Triantos S, Hu P, Shalaby W, McGowan T, Monk BJ, Demetri GD. Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med. 2021 Jun;10(11):3565-3574. doi: 10.1002/cam4.3903. Epub 2021 May 07. PMID: 33960681; PMCID: PMC8178483.
Copy Download .nbib Format: NLM
Clinical trials, adaptability and the COVID-19 pandemic.

Gynecologic oncology reports

Eskander RN, Pothuri B, Randall L, O'Malley D, Slomovitz B, Moore K, Coleman R, Herzog T, Monk BJ, Copeland L.
PMID: 33319009
Gynecol Oncol Rep. 2021 Feb;35:100680. doi: 10.1016/j.gore.2020.100680. Epub 2020 Dec 08.

Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.

Cite
Eskander RN, Pothuri B, Randall L, et al. Clinical trials, adaptability and the COVID-19 pandemic. Gynecol Oncol Rep. 2020;35:100680doi: 10.1016/j.gore.2020.100680.
Eskander, R. N., Pothuri, B., Randall, L., O'Malley, D., Slomovitz, B., Moore, K., Coleman, R., Herzog, T., Monk, B. J., & Copeland, L. (2021). Clinical trials, adaptability and the COVID-19 pandemic. Gynecologic oncology reports, 35100680. https://doi.org/10.1016/j.gore.2020.100680
Eskander, Ramez N, et al. "Clinical trials, adaptability and the COVID-19 pandemic." Gynecologic oncology reports vol. 35 (2021): 100680. doi: https://doi.org/10.1016/j.gore.2020.100680
Eskander RN, Pothuri B, Randall L, O'Malley D, Slomovitz B, Moore K, Coleman R, Herzog T, Monk BJ, Copeland L. Clinical trials, adaptability and the COVID-19 pandemic. Gynecol Oncol Rep. 2021 Feb;35:100680. doi: 10.1016/j.gore.2020.100680. Epub 2020 Dec 08. PMID: 33319009; PMCID: PMC7723439.
Copy Download .nbib Format: NLM
Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Xie C, Duffy AG, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Bonilla CM, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF.
PMID: 33397682
Clin Cancer Res. 2021 Jan 01;27(1):358. doi: 10.1158/1078-0432.CCR-20-4640.

No abstract available.

Cite
Xie C, Duffy AG, Brar G, et al. Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2021;27(1):358doi: 10.1158/1078-0432.CCR-20-4640.
Xie, C., Duffy, A. G., Brar, G., Fioravanti, S., Mabry-Hrones, D., Walker, M., Bonilla, C. M., Wood, B. J., Citrin, D. E., Gil Ramirez, E. M., Escorcia, F. E., Redd, B., Hernandez, J. M., Davis, J. L., Gasmi, B., Kleiner, D., Steinberg, S. M., Jones, J. C., & Greten, T. F. (2021). Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(1), 358. https://doi.org/10.1158/1078-0432.CCR-20-4640
Xie, Changqing, et al. "Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,1 (2021): 358. doi: https://doi.org/10.1158/1078-0432.CCR-20-4640
Xie C, Duffy AG, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Bonilla CM, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF. Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2021 Jan 01;27(1):358. doi: 10.1158/1078-0432.CCR-20-4640. PMID: 33397682.
Copy Download .nbib Format: NLM
Predictors of .

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Mena E, Rowe SP, Shih JH, Lindenberg L, Turkbey B, Fourquet A, Lin FI, Adler S, Eclarinal P, McKinney YL, Citrin DE, Dahut W, Wood BJ, Chang R, Levy E, Merino M, Gorin MA, Pomper MG, Pinto PA, Eary JF, Choyke PL, Pienta KJ.
PMID: 34916246
J Nucl Med. 2021 Dec 16; doi: 10.2967/jnumed.121.262347. Epub 2021 Dec 16.

No abstract available.

Cite
Mena E, Rowe SP, Shih JH, et al. Predictors of . J Nucl Med. 2021;doi: 10.2967/jnumed.121.262347.
Mena, E., Rowe, S. P., Shih, J. H., Lindenberg, L., Turkbey, B., Fourquet, A., Lin, F. I., Adler, S., Eclarinal, P., McKinney, Y. L., Citrin, D. E., Dahut, W., Wood, B. J., Chang, R., Levy, E., Merino, M., Gorin, M. A., Pomper, M. G., Pinto, P. A., Eary, J. F., Choyke, P. L., & Pienta, K. J. (2021). Predictors of . Journal of nuclear medicine : official publication, Society of Nuclear Medicine, . https://doi.org/10.2967/jnumed.121.262347
Mena, Esther, et al. "Predictors of ." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. (2021). doi: https://doi.org/10.2967/jnumed.121.262347
Mena E, Rowe SP, Shih JH, Lindenberg L, Turkbey B, Fourquet A, Lin FI, Adler S, Eclarinal P, McKinney YL, Citrin DE, Dahut W, Wood BJ, Chang R, Levy E, Merino M, Gorin MA, Pomper MG, Pinto PA, Eary JF, Choyke PL, Pienta KJ. Predictors of . J Nucl Med. 2021 Dec 16; doi: 10.2967/jnumed.121.262347. Epub 2021 Dec 16. PMID: 34916246.
Copy Download .nbib Format: NLM
Image-Guided Robotics for Standardized and Automated Biopsy and Ablation.

Seminars in interventional radiology

Christou AS, Amalou A, Lee H, Rivera J, Li R, Kassin MT, Varble N, Tsz Ho Tse Z, Xu S, Wood BJ.
PMID: 34853503
Semin Intervent Radiol. 2021 Nov 24;38(5):565-575. doi: 10.1055/s-0041-1739164. eCollection 2021 Dec.

Image-guided robotics for biopsy and ablation aims to minimize procedure times, reduce needle manipulations, radiation, and complications, and enable treatment of larger and more complex tumors, while facilitating standardization for more uniform and improved outcomes. Robotic navigation of needles...

Cite
Christou AS, Amalou A, Lee H, et al. Image-Guided Robotics for Standardized and Automated Biopsy and Ablation. Semin Intervent Radiol. 2021;38(5):565-575doi: 10.1055/s-0041-1739164.
Christou, A. S., Amalou, A., Lee, H., Rivera, J., Li, R., Kassin, M. T., Varble, N., Tsz Ho Tse, Z., Xu, S., & Wood, B. J. (2021). Image-Guided Robotics for Standardized and Automated Biopsy and Ablation. Seminars in interventional radiology, 38(5), 565-575. https://doi.org/10.1055/s-0041-1739164
Christou, Anna S, et al. "Image-Guided Robotics for Standardized and Automated Biopsy and Ablation." Seminars in interventional radiology vol. 38,5 (2021): 565-575. doi: https://doi.org/10.1055/s-0041-1739164
Christou AS, Amalou A, Lee H, Rivera J, Li R, Kassin MT, Varble N, Tsz Ho Tse Z, Xu S, Wood BJ. Image-Guided Robotics for Standardized and Automated Biopsy and Ablation. Semin Intervent Radiol. 2021 Nov 24;38(5):565-575. doi: 10.1055/s-0041-1739164. eCollection 2021 Dec. PMID: 34853503; PMCID: PMC8612841.
Copy Download .nbib Format: NLM
Sequential Chemotherapy for Early-Stage, Post-Radical Hysterectomy Cervical Cancer: Are the STARS Aligned?.

JAMA oncology

Randall LM, Mayadev J, Monk BJ.
PMID: 33443572
JAMA Oncol. 2021 Mar 01;7(3):353-354. doi: 10.1001/jamaoncol.2020.7184.

No abstract available.

Cite
Randall LM, Mayadev J, Monk BJ. Sequential Chemotherapy for Early-Stage, Post-Radical Hysterectomy Cervical Cancer: Are the STARS Aligned?. JAMA Oncol. 2021;7(3):353-354doi: 10.1001/jamaoncol.2020.7184.
Randall, L. M., Mayadev, J., & Monk, B. J. (2021). Sequential Chemotherapy for Early-Stage, Post-Radical Hysterectomy Cervical Cancer: Are the STARS Aligned?. JAMA oncology, 7(3), 353-354. https://doi.org/10.1001/jamaoncol.2020.7184
Randall, Leslie M, et al. "Sequential Chemotherapy for Early-Stage, Post-Radical Hysterectomy Cervical Cancer: Are the STARS Aligned?." JAMA oncology vol. 7,3 (2021): 353-354. doi: https://doi.org/10.1001/jamaoncol.2020.7184
Randall LM, Mayadev J, Monk BJ. Sequential Chemotherapy for Early-Stage, Post-Radical Hysterectomy Cervical Cancer: Are the STARS Aligned?. JAMA Oncol. 2021 Mar 01;7(3):353-354. doi: 10.1001/jamaoncol.2020.7184. PMID: 33443572.
Copy Download .nbib Format: NLM
A Clinically Driven Task-Based Comparison of Photon Counting and Conventional Energy Integrating CT for Soft Tissue, Vascular, and High-Resolution Tasks.

IEEE transactions on radiation and plasma medical sciences

Rajagopal JR, Sahbaee P, Farhadi F, Solomon JB, Ramirez-Giraldo JC, Pritchard WF, Wood BJ, Jones EC, Samei E.
PMID: 34250326
IEEE Trans Radiat Plasma Med Sci. 2021 Jul;5(4):588-595. doi: 10.1109/trpms.2020.3019954. Epub 2020 Aug 27.

Photon-counting CT detectors are the next step in advancing CT system development and will replace the current energy integrating detectors (EID) in CT systems in the near future. In this context, the performance of PCCT was compared to EID...

Cite
Rajagopal JR, Sahbaee P, Farhadi F, et al. A Clinically Driven Task-Based Comparison of Photon Counting and Conventional Energy Integrating CT for Soft Tissue, Vascular, and High-Resolution Tasks. IEEE Trans Radiat Plasma Med Sci. 2020;5(4):588-595doi: 10.1109/trpms.2020.3019954.
Rajagopal, J. R., Sahbaee, P., Farhadi, F., Solomon, J. B., Ramirez-Giraldo, J. C., Pritchard, W. F., Wood, B. J., Jones, E. C., & Samei, E. (2021). A Clinically Driven Task-Based Comparison of Photon Counting and Conventional Energy Integrating CT for Soft Tissue, Vascular, and High-Resolution Tasks. IEEE transactions on radiation and plasma medical sciences, 5(4), 588-595. https://doi.org/10.1109/trpms.2020.3019954
Rajagopal, Jayasai R, et al. "A Clinically Driven Task-Based Comparison of Photon Counting and Conventional Energy Integrating CT for Soft Tissue, Vascular, and High-Resolution Tasks." IEEE transactions on radiation and plasma medical sciences vol. 5,4 (2021): 588-595. doi: https://doi.org/10.1109/trpms.2020.3019954
Rajagopal JR, Sahbaee P, Farhadi F, Solomon JB, Ramirez-Giraldo JC, Pritchard WF, Wood BJ, Jones EC, Samei E. A Clinically Driven Task-Based Comparison of Photon Counting and Conventional Energy Integrating CT for Soft Tissue, Vascular, and High-Resolution Tasks. IEEE Trans Radiat Plasma Med Sci. 2021 Jul;5(4):588-595. doi: 10.1109/trpms.2020.3019954. Epub 2020 Aug 27. PMID: 34250326; PMCID: PMC8269971.
Copy Download .nbib Format: NLM
Cytomegalovirus Transmitted From Mother's Own Milk to a Growth-Restricted Extremely Preterm Infant: A Case Report.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses

Work BJ, Volder C, Fenger-Gron J, Zachariassen G.
PMID: 33843784
Adv Neonatal Care. 2021 Apr 08; doi: 10.1097/ANC.0000000000000860. Epub 2021 Apr 08.

BACKGROUND: Mother's own milk (MOM) is considered the optimal nutrition for preterm infants. Unfortunately, MOM can contain human cytomegalovirus (HCMV), which can be transmitted to the infants. Postnatal HCMV infection in very preterm infants can lead to organ failure.CLINICAL...

Cite
Work BJ, Volder C, Fenger-Gron J, et al. Cytomegalovirus Transmitted From Mother's Own Milk to a Growth-Restricted Extremely Preterm Infant: A Case Report. Adv Neonatal Care. 2021;doi: 10.1097/ANC.0000000000000860.
Work, B. J., Volder, C., Fenger-Gron, J., & Zachariassen, G. (2021). Cytomegalovirus Transmitted From Mother's Own Milk to a Growth-Restricted Extremely Preterm Infant: A Case Report. Advances in neonatal care : official journal of the National Association of Neonatal Nurses, . https://doi.org/10.1097/ANC.0000000000000860
Work, Benedicte Juul, et al. "Cytomegalovirus Transmitted From Mother's Own Milk to a Growth-Restricted Extremely Preterm Infant: A Case Report." Advances in neonatal care : official journal of the National Association of Neonatal Nurses vol. (2021). doi: https://doi.org/10.1097/ANC.0000000000000860
Work BJ, Volder C, Fenger-Gron J, Zachariassen G. Cytomegalovirus Transmitted From Mother's Own Milk to a Growth-Restricted Extremely Preterm Infant: A Case Report. Adv Neonatal Care. 2021 Apr 08; doi: 10.1097/ANC.0000000000000860. Epub 2021 Apr 08. PMID: 33843784.
Copy Download .nbib Format: NLM
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.

Journal of the National Cancer Institute

Wenzel L, Osann K, McKinney C, Cella D, Fulci G, Scroggins MJ, Lankes HA, Wang V, Nephew KP, Maxwell GL, Mok SC, Conrads TP, Miller A, Mannel RS, Gray HJ, Hanjani P, Huh WK, Spirtos N, Leitao MM, Glaser G, Sharma SK, Santin AD, Sperduto P, Lele SB, Burger RA, Monk BJ, Birrer M.
PMID: 33729494
J Natl Cancer Inst. 2021 Oct 01;113(10):1369-1378. doi: 10.1093/jnci/djab034.

BACKGROUND: There is a critical need to identify patient characteristics associated with long-term ovarian cancer survival.METHODS: Quality of life (QOL), measured by the Functional Assessment of Cancer Therapy-Ovarian-Trial Outcome Index (FACT-O-TOI), including physical, functional, and ovarian-specific subscales, was compared...

Cite
Wenzel L, Osann K, McKinney C, et al. Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. J Natl Cancer Inst. 2021;113(10):1369-1378doi: 10.1093/jnci/djab034.
Wenzel, L., Osann, K., McKinney, C., Cella, D., Fulci, G., Scroggins, M. J., Lankes, H. A., Wang, V., Nephew, K. P., Maxwell, G. L., Mok, S. C., Conrads, T. P., Miller, A., Mannel, R. S., Gray, H. J., Hanjani, P., Huh, W. K., Spirtos, N., Leitao, M. M., Glaser, G., Sharma, S. K., Santin, A. D., Sperduto, P., Lele, S. B., Burger, R. A., Monk, B. J., & Birrer, M. (2021). Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. Journal of the National Cancer Institute, 113(10), 1369-1378. https://doi.org/10.1093/jnci/djab034
Wenzel, Lari, et al. "Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival." Journal of the National Cancer Institute vol. 113,10 (2021): 1369-1378. doi: https://doi.org/10.1093/jnci/djab034
Wenzel L, Osann K, McKinney C, Cella D, Fulci G, Scroggins MJ, Lankes HA, Wang V, Nephew KP, Maxwell GL, Mok SC, Conrads TP, Miller A, Mannel RS, Gray HJ, Hanjani P, Huh WK, Spirtos N, Leitao MM, Glaser G, Sharma SK, Santin AD, Sperduto P, Lele SB, Burger RA, Monk BJ, Birrer M. Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. J Natl Cancer Inst. 2021 Oct 01;113(10):1369-1378. doi: 10.1093/jnci/djab034. PMID: 33729494; PMCID: PMC8486331.
Copy Download .nbib Format: NLM
Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study.

European urology oncology

Ahdoot M, Lebastchi AH, Long L, Wilbur AR, Gomella PT, Mehralivand S, Daneshvar MA, Yerram NK, O'Connor LP, Wang AZ, Gurram S, Bloom J, Siddiqui MM, Linehan WM, Merino M, Choyke PL, Pinsky P, Parnes H, Shih JH, Turkbey B, Wood BJ, Pinto PA.
PMID: 33846112
Eur Urol Oncol. 2021 Apr 10; doi: 10.1016/j.euo.2021.03.004. Epub 2021 Apr 10.

BACKGROUND: While magnetic resonance imaging (MRI)-targeted biopsy (TBx) results in better prostate cancer (PCa) detection relative to systematic biopsy (SBx), the combination of both methods increases clinically significant PCa detection relative to either Bx method alone. However, combined Bx...

Cite
Ahdoot M, Lebastchi AH, Long L, et al. Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study. Eur Urol Oncol. 2021;doi: 10.1016/j.euo.2021.03.004.
Ahdoot, M., Lebastchi, A. H., Long, L., Wilbur, A. R., Gomella, P. T., Mehralivand, S., Daneshvar, M. A., Yerram, N. K., O'Connor, L. P., Wang, A. Z., Gurram, S., Bloom, J., Siddiqui, M. M., Linehan, W. M., Merino, M., Choyke, P. L., Pinsky, P., Parnes, H., Shih, J. H., Turkbey, B., Wood, B. J., Pinto, P. A. (2021). Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study. European urology oncology, . https://doi.org/10.1016/j.euo.2021.03.004
Ahdoot, Michael, et al. "Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study." European urology oncology vol. (2021). doi: https://doi.org/10.1016/j.euo.2021.03.004
Ahdoot M, Lebastchi AH, Long L, Wilbur AR, Gomella PT, Mehralivand S, Daneshvar MA, Yerram NK, O'Connor LP, Wang AZ, Gurram S, Bloom J, Siddiqui MM, Linehan WM, Merino M, Choyke PL, Pinsky P, Parnes H, Shih JH, Turkbey B, Wood BJ, Pinto PA. Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study. Eur Urol Oncol. 2021 Apr 10; doi: 10.1016/j.euo.2021.03.004. Epub 2021 Apr 10. PMID: 33846112.
Copy Download .nbib Format: NLM
Prediction models of treatment response in lupus nephritis.

Kidney international

Ayoub I, Wolf BJ, Geng L, Song H, Khatiwada A, Tsao BP, Oates JC, Rovin BH.
PMID: 34871620
Kidney Int. 2021 Dec 03; doi: 10.1016/j.kint.2021.11.014. Epub 2021 Dec 03.

In order to develop prediction models of one-year treatment response in lupus nephritis, an approach using machine learning to combine traditional clinical data and novel urine biomarkers was undertaken. Contemporary lupus nephritis biomarkers were identified through an unbiased PubMed...

Cite
Ayoub I, Wolf BJ, Geng L, et al. Prediction models of treatment response in lupus nephritis. Kidney Int. 2021;doi: 10.1016/j.kint.2021.11.014.
Ayoub, I., Wolf, B. J., Geng, L., Song, H., Khatiwada, A., Tsao, B. P., Oates, J. C., & Rovin, B. H. (2021). Prediction models of treatment response in lupus nephritis. Kidney international, . https://doi.org/10.1016/j.kint.2021.11.014
Ayoub, Isabelle, et al. "Prediction models of treatment response in lupus nephritis." Kidney international vol. (2021). doi: https://doi.org/10.1016/j.kint.2021.11.014
Ayoub I, Wolf BJ, Geng L, Song H, Khatiwada A, Tsao BP, Oates JC, Rovin BH. Prediction models of treatment response in lupus nephritis. Kidney Int. 2021 Dec 03; doi: 10.1016/j.kint.2021.11.014. Epub 2021 Dec 03. PMID: 34871620.
Copy Download .nbib Format: NLM
Electrochemical treatment of ex vivo human abdominal skin and potential use in scar management: A pilot study.

Scars, burns & healing

Hutchison DM, Hakimi AA, Wijayaweera A, Seo S, Hong EM, Pham TT, Bircan M, Sivoraphonh R, Dunn B, Kobayashi MR, Kim S, Wong BJ.
PMID: 33796338
Scars Burn Heal. 2021 Mar 16;7:2059513120988532. doi: 10.1177/2059513120988532. eCollection 2021.

INTRODUCTION: Scar treatments aim to address pathologic collagen deposition; however, they can be expensive or difficult to control. Electrochemical therapy (ECT) offers a simple alternative treatment. The purpose of this study is to examine the acid-base and histological changes...

Cite
Hutchison DM, Hakimi AA, Wijayaweera A, et al. Electrochemical treatment of ex vivo human abdominal skin and potential use in scar management: A pilot study. Scars Burn Heal. 2021;7:2059513120988532doi: 10.1177/2059513120988532.
Hutchison, D. M., Hakimi, A. A., Wijayaweera, A., Seo, S., Hong, E. M., Pham, T. T., Bircan, M., Sivoraphonh, R., Dunn, B., Kobayashi, M. R., Kim, S., & Wong, B. J. (2021). Electrochemical treatment of ex vivo human abdominal skin and potential use in scar management: A pilot study. Scars, burns & healing, 72059513120988532. https://doi.org/10.1177/2059513120988532
Hutchison, Dana M, et al. "Electrochemical treatment of ex vivo human abdominal skin and potential use in scar management: A pilot study." Scars, burns & healing vol. 7 (2021): 2059513120988532. doi: https://doi.org/10.1177/2059513120988532
Hutchison DM, Hakimi AA, Wijayaweera A, Seo S, Hong EM, Pham TT, Bircan M, Sivoraphonh R, Dunn B, Kobayashi MR, Kim S, Wong BJ. Electrochemical treatment of ex vivo human abdominal skin and potential use in scar management: A pilot study. Scars Burn Heal. 2021 Mar 16;7:2059513120988532. doi: 10.1177/2059513120988532. eCollection 2021. PMID: 33796338; PMCID: PMC7970177.
Copy Download .nbib Format: NLM
Showing 277 to 288 of 288 entries